Blood tests for kidney disease
Part of Immune system & allergy, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at blood samples from people with kidney problems to learn more about the condition and find better ways to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a blood test showing low albumin (a protein in your blood).
- You have high levels of protein in your urine, which can be detected by a simple urine test.
- You are scheduled for a kidney biopsy (a procedure where a small piece of kidney is taken for testing).
- You have not had a kidney transplant or a previous kidney biopsy.
- You can understand written information in Danish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for children (and some newly diagnosed patients) who have nephrotic syndrome—kidneys leaking a lot of protein. It aims to better understand the kidney condition (sometimes using biopsy) and support future care decisions.
This study builds a kidney tissue “library” to help researchers analyze kidney disease in newer ways. It may help by improving how glomerular (kidney filter) diseases are understood over time, using samples from people who already had a biopsy.
This study looks for specific proteins (autoantibodies) in your blood that may be linked to certain kidney diseases. It aims to better understand the immune system's role in minimal change disease and FSGS, which could lead to better treatments.
This study looks at how common diabetic kidney damage is in people with type 2 diabetes, and which factors can predict it. If you qualify, you may be asked to have a kidney biopsy to understand what’s happening inside your kidneys.
This study looks at whether simple blood tests can help doctors better understand and track kidney problems that occur in people with lupus. The goal is to see if these markers can predict how the disease will progress, which could help guide treatment.
This study looks at simple blood tests to see if certain markers of inflammation and platelet levels are different in people with diabetic kidney disease compared to healthy people. The results might help doctors find kidney problems earlier in people with type 2 diabetes.
Hear when a new Nephrotic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.